nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—PTGS1—esophageal cancer	0.686	1	CbGaD
Trabectedin—Hepatic pain—Capecitabine—esophageal cancer	0.0124	0.0968	CcSEcCtD
Trabectedin—Neutropenic sepsis—Capecitabine—esophageal cancer	0.00598	0.0465	CcSEcCtD
Trabectedin—Extravasation—Carboplatin—esophageal cancer	0.00549	0.0428	CcSEcCtD
Trabectedin—Peripheral sensory neuropathy—Capecitabine—esophageal cancer	0.00363	0.0282	CcSEcCtD
Trabectedin—Blood albumin decreased—Methotrexate—esophageal cancer	0.00353	0.0275	CcSEcCtD
Trabectedin—Febrile neutropenia—Cisplatin—esophageal cancer	0.00234	0.0182	CcSEcCtD
Trabectedin—Mucosal inflammation—Capecitabine—esophageal cancer	0.00187	0.0146	CcSEcCtD
Trabectedin—Hepatotoxicity—Cisplatin—esophageal cancer	0.00182	0.0142	CcSEcCtD
Trabectedin—Necrosis—Cisplatin—esophageal cancer	0.00179	0.0139	CcSEcCtD
Trabectedin—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.00174	0.0136	CcSEcCtD
Trabectedin—Febrile neutropenia—Capecitabine—esophageal cancer	0.00172	0.0134	CcSEcCtD
Trabectedin—Infection—Carboplatin—esophageal cancer	0.0017	0.0132	CcSEcCtD
Trabectedin—Liver injury—Cisplatin—esophageal cancer	0.00167	0.013	CcSEcCtD
Trabectedin—Extravasation—Cisplatin—esophageal cancer	0.00161	0.0125	CcSEcCtD
Trabectedin—Hepatomegaly—Capecitabine—esophageal cancer	0.00146	0.0114	CcSEcCtD
Trabectedin—Mucosal inflammation—Methotrexate—esophageal cancer	0.00139	0.0108	CcSEcCtD
Trabectedin—Body temperature increased—Carboplatin—esophageal cancer	0.00135	0.0105	CcSEcCtD
Trabectedin—Hepatotoxicity—Capecitabine—esophageal cancer	0.00134	0.0104	CcSEcCtD
Trabectedin—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.0013	0.0101	CcSEcCtD
Trabectedin—Febrile neutropenia—Methotrexate—esophageal cancer	0.00128	0.00998	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.00114	0.00887	CcSEcCtD
Trabectedin—Pulmonary embolism—Capecitabine—esophageal cancer	0.00104	0.00807	CcSEcCtD
Trabectedin—Injection site reaction—Capecitabine—esophageal cancer	0.00103	0.00802	CcSEcCtD
Trabectedin—Hepatotoxicity—Methotrexate—esophageal cancer	0.000999	0.00778	CcSEcCtD
Trabectedin—Necrosis—Methotrexate—esophageal cancer	0.000983	0.00765	CcSEcCtD
Trabectedin—Blood creatinine increased—Cisplatin—esophageal cancer	0.000956	0.00744	CcSEcCtD
Trabectedin—Dehydration—Cisplatin—esophageal cancer	0.000949	0.00739	CcSEcCtD
Trabectedin—Hypokalaemia—Cisplatin—esophageal cancer	0.000929	0.00723	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000919	0.00715	CcSEcCtD
Trabectedin—Sepsis—Capecitabine—esophageal cancer	0.0009	0.007	CcSEcCtD
Trabectedin—Extravasation—Methotrexate—esophageal cancer	0.000884	0.00688	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000865	0.00673	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000849	0.0066	CcSEcCtD
Trabectedin—Pancytopenia—Cisplatin—esophageal cancer	0.000838	0.00652	CcSEcCtD
Trabectedin—Hepatic failure—Capecitabine—esophageal cancer	0.000837	0.00652	CcSEcCtD
Trabectedin—Pulmonary embolism—Methotrexate—esophageal cancer	0.000772	0.00601	CcSEcCtD
Trabectedin—Stomatitis—Cisplatin—esophageal cancer	0.000767	0.00597	CcSEcCtD
Trabectedin—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000744	0.00579	CcSEcCtD
Trabectedin—Blood creatinine increased—Capecitabine—esophageal cancer	0.000705	0.00549	CcSEcCtD
Trabectedin—Dehydration—Capecitabine—esophageal cancer	0.0007	0.00545	CcSEcCtD
Trabectedin—Connective tissue disorder—Cisplatin—esophageal cancer	0.000694	0.0054	CcSEcCtD
Trabectedin—Abdominal pain upper—Capecitabine—esophageal cancer	0.000687	0.00535	CcSEcCtD
Trabectedin—Pulmonary oedema—Methotrexate—esophageal cancer	0.000687	0.00535	CcSEcCtD
Trabectedin—Hypokalaemia—Capecitabine—esophageal cancer	0.000685	0.00533	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000678	0.00527	CcSEcCtD
Trabectedin—Sepsis—Methotrexate—esophageal cancer	0.00067	0.00521	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000664	0.00516	CcSEcCtD
Trabectedin—Flushing—Cisplatin—esophageal cancer	0.000655	0.0051	CcSEcCtD
Trabectedin—Mediastinal disorder—Cisplatin—esophageal cancer	0.000636	0.00495	CcSEcCtD
Trabectedin—Alopecia—Cisplatin—esophageal cancer	0.000624	0.00486	CcSEcCtD
Trabectedin—Hepatic failure—Methotrexate—esophageal cancer	0.000623	0.00485	CcSEcCtD
Trabectedin—Pancytopenia—Capecitabine—esophageal cancer	0.000618	0.00481	CcSEcCtD
Trabectedin—Malnutrition—Cisplatin—esophageal cancer	0.000615	0.00478	CcSEcCtD
Trabectedin—Neutropenia—Capecitabine—esophageal cancer	0.000608	0.00473	CcSEcCtD
Trabectedin—Weight decreased—Capecitabine—esophageal cancer	0.000588	0.00458	CcSEcCtD
Trabectedin—Infestation NOS—Capecitabine—esophageal cancer	0.00058	0.00451	CcSEcCtD
Trabectedin—Infestation—Capecitabine—esophageal cancer	0.00058	0.00451	CcSEcCtD
Trabectedin—Anaemia—Cisplatin—esophageal cancer	0.000568	0.00442	CcSEcCtD
Trabectedin—Jaundice—Capecitabine—esophageal cancer	0.000565	0.0044	CcSEcCtD
Trabectedin—Stomatitis—Capecitabine—esophageal cancer	0.000565	0.0044	CcSEcCtD
Trabectedin—Leukopenia—Cisplatin—esophageal cancer	0.00055	0.00428	CcSEcCtD
Trabectedin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000548	0.00427	CcSEcCtD
Trabectedin—Agranulocytosis—Capecitabine—esophageal cancer	0.000541	0.00421	CcSEcCtD
Trabectedin—Myalgia—Cisplatin—esophageal cancer	0.000523	0.00407	CcSEcCtD
Trabectedin—Haemoglobin—Capecitabine—esophageal cancer	0.000523	0.00407	CcSEcCtD
Trabectedin—Haemorrhage—Capecitabine—esophageal cancer	0.000521	0.00405	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00052	0.00404	CcSEcCtD
Trabectedin—Oedema peripheral—Capecitabine—esophageal cancer	0.000513	0.00399	CcSEcCtD
Trabectedin—Connective tissue disorder—Capecitabine—esophageal cancer	0.000512	0.00398	CcSEcCtD
Trabectedin—Oedema—Cisplatin—esophageal cancer	0.000502	0.0039	CcSEcCtD
Trabectedin—Infection—Cisplatin—esophageal cancer	0.000498	0.00388	CcSEcCtD
Trabectedin—Nervous system disorder—Cisplatin—esophageal cancer	0.000492	0.00383	CcSEcCtD
Trabectedin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000491	0.00382	CcSEcCtD
Trabectedin—Skin disorder—Cisplatin—esophageal cancer	0.000487	0.00379	CcSEcCtD
Trabectedin—Flushing—Capecitabine—esophageal cancer	0.000483	0.00376	CcSEcCtD
Trabectedin—Anorexia—Cisplatin—esophageal cancer	0.000478	0.00372	CcSEcCtD
Trabectedin—Angiopathy—Capecitabine—esophageal cancer	0.000472	0.00368	CcSEcCtD
Trabectedin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000469	0.00365	CcSEcCtD
Trabectedin—Hypotension—Cisplatin—esophageal cancer	0.000469	0.00365	CcSEcCtD
Trabectedin—Alopecia—Capecitabine—esophageal cancer	0.00046	0.00358	CcSEcCtD
Trabectedin—Pancytopenia—Methotrexate—esophageal cancer	0.00046	0.00358	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000457	0.00356	CcSEcCtD
Trabectedin—Mental disorder—Capecitabine—esophageal cancer	0.000456	0.00355	CcSEcCtD
Trabectedin—Malnutrition—Capecitabine—esophageal cancer	0.000453	0.00353	CcSEcCtD
Trabectedin—Neutropenia—Methotrexate—esophageal cancer	0.000453	0.00352	CcSEcCtD
Trabectedin—Paraesthesia—Cisplatin—esophageal cancer	0.000451	0.00351	CcSEcCtD
Trabectedin—Dyspnoea—Cisplatin—esophageal cancer	0.000447	0.00348	CcSEcCtD
Trabectedin—Dysgeusia—Capecitabine—esophageal cancer	0.000444	0.00345	CcSEcCtD
Trabectedin—Back pain—Capecitabine—esophageal cancer	0.000438	0.00341	CcSEcCtD
Trabectedin—Decreased appetite—Cisplatin—esophageal cancer	0.000436	0.00339	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000433	0.00337	CcSEcCtD
Trabectedin—Infestation NOS—Methotrexate—esophageal cancer	0.000432	0.00336	CcSEcCtD
Trabectedin—Infestation—Methotrexate—esophageal cancer	0.000432	0.00336	CcSEcCtD
Trabectedin—Stomatitis—Methotrexate—esophageal cancer	0.000421	0.00327	CcSEcCtD
Trabectedin—Anaemia—Capecitabine—esophageal cancer	0.000419	0.00326	CcSEcCtD
Trabectedin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000408	0.00318	CcSEcCtD
Trabectedin—Syncope—Capecitabine—esophageal cancer	0.000406	0.00316	CcSEcCtD
Trabectedin—Leukopenia—Capecitabine—esophageal cancer	0.000406	0.00316	CcSEcCtD
Trabectedin—Agranulocytosis—Methotrexate—esophageal cancer	0.000403	0.00313	CcSEcCtD
Trabectedin—Loss of consciousness—Capecitabine—esophageal cancer	0.000398	0.0031	CcSEcCtD
Trabectedin—Body temperature increased—Cisplatin—esophageal cancer	0.000397	0.00309	CcSEcCtD
Trabectedin—Cough—Capecitabine—esophageal cancer	0.000395	0.00308	CcSEcCtD
Trabectedin—Haemoglobin—Methotrexate—esophageal cancer	0.000389	0.00303	CcSEcCtD
Trabectedin—Haemorrhage—Methotrexate—esophageal cancer	0.000388	0.00302	CcSEcCtD
Trabectedin—Myalgia—Capecitabine—esophageal cancer	0.000386	0.003	CcSEcCtD
Trabectedin—Arthralgia—Capecitabine—esophageal cancer	0.000386	0.003	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000383	0.00298	CcSEcCtD
Trabectedin—Oedema—Capecitabine—esophageal cancer	0.00037	0.00288	CcSEcCtD
Trabectedin—Hypersensitivity—Cisplatin—esophageal cancer	0.00037	0.00288	CcSEcCtD
Trabectedin—Infection—Capecitabine—esophageal cancer	0.000367	0.00286	CcSEcCtD
Trabectedin—Shock—Capecitabine—esophageal cancer	0.000364	0.00283	CcSEcCtD
Trabectedin—Nervous system disorder—Capecitabine—esophageal cancer	0.000363	0.00282	CcSEcCtD
Trabectedin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000362	0.00282	CcSEcCtD
Trabectedin—Asthenia—Cisplatin—esophageal cancer	0.00036	0.0028	CcSEcCtD
Trabectedin—Skin disorder—Capecitabine—esophageal cancer	0.000359	0.0028	CcSEcCtD
Trabectedin—Anorexia—Capecitabine—esophageal cancer	0.000353	0.00274	CcSEcCtD
Trabectedin—Angiopathy—Methotrexate—esophageal cancer	0.000352	0.00274	CcSEcCtD
Trabectedin—Mediastinal disorder—Methotrexate—esophageal cancer	0.000349	0.00272	CcSEcCtD
Trabectedin—Hypotension—Capecitabine—esophageal cancer	0.000346	0.00269	CcSEcCtD
Trabectedin—Diarrhoea—Cisplatin—esophageal cancer	0.000343	0.00267	CcSEcCtD
Trabectedin—Alopecia—Methotrexate—esophageal cancer	0.000342	0.00266	CcSEcCtD
Trabectedin—Mental disorder—Methotrexate—esophageal cancer	0.00034	0.00264	CcSEcCtD
Trabectedin—Malnutrition—Methotrexate—esophageal cancer	0.000337	0.00263	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000337	0.00262	CcSEcCtD
Trabectedin—Insomnia—Capecitabine—esophageal cancer	0.000335	0.0026	CcSEcCtD
Trabectedin—Paraesthesia—Capecitabine—esophageal cancer	0.000332	0.00258	CcSEcCtD
Trabectedin—Dysgeusia—Methotrexate—esophageal cancer	0.00033	0.00257	CcSEcCtD
Trabectedin—Dyspnoea—Capecitabine—esophageal cancer	0.00033	0.00257	CcSEcCtD
Trabectedin—Back pain—Methotrexate—esophageal cancer	0.000326	0.00254	CcSEcCtD
Trabectedin—Dyspepsia—Capecitabine—esophageal cancer	0.000326	0.00253	CcSEcCtD
Trabectedin—Decreased appetite—Capecitabine—esophageal cancer	0.000321	0.0025	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000319	0.00248	CcSEcCtD
Trabectedin—Vomiting—Cisplatin—esophageal cancer	0.000319	0.00248	CcSEcCtD
Trabectedin—Fatigue—Capecitabine—esophageal cancer	0.000319	0.00248	CcSEcCtD
Trabectedin—Rash—Cisplatin—esophageal cancer	0.000316	0.00246	CcSEcCtD
Trabectedin—Constipation—Capecitabine—esophageal cancer	0.000316	0.00246	CcSEcCtD
Trabectedin—Dermatitis—Cisplatin—esophageal cancer	0.000316	0.00246	CcSEcCtD
Trabectedin—Anaemia—Methotrexate—esophageal cancer	0.000312	0.00243	CcSEcCtD
Trabectedin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000302	0.00235	CcSEcCtD
Trabectedin—Leukopenia—Methotrexate—esophageal cancer	0.000302	0.00235	CcSEcCtD
Trabectedin—Nausea—Cisplatin—esophageal cancer	0.000298	0.00232	CcSEcCtD
Trabectedin—Cough—Methotrexate—esophageal cancer	0.000294	0.00229	CcSEcCtD
Trabectedin—Body temperature increased—Capecitabine—esophageal cancer	0.000292	0.00228	CcSEcCtD
Trabectedin—Abdominal pain—Capecitabine—esophageal cancer	0.000292	0.00228	CcSEcCtD
Trabectedin—Arthralgia—Methotrexate—esophageal cancer	0.000287	0.00223	CcSEcCtD
Trabectedin—Myalgia—Methotrexate—esophageal cancer	0.000287	0.00223	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000285	0.00222	CcSEcCtD
Trabectedin—Infection—Methotrexate—esophageal cancer	0.000274	0.00213	CcSEcCtD
Trabectedin—Hypersensitivity—Capecitabine—esophageal cancer	0.000272	0.00212	CcSEcCtD
Trabectedin—Nervous system disorder—Methotrexate—esophageal cancer	0.00027	0.0021	CcSEcCtD
Trabectedin—Thrombocytopenia—Methotrexate—esophageal cancer	0.00027	0.0021	CcSEcCtD
Trabectedin—Skin disorder—Methotrexate—esophageal cancer	0.000267	0.00208	CcSEcCtD
Trabectedin—Asthenia—Capecitabine—esophageal cancer	0.000265	0.00206	CcSEcCtD
Trabectedin—Anorexia—Methotrexate—esophageal cancer	0.000262	0.00204	CcSEcCtD
Trabectedin—Hypotension—Methotrexate—esophageal cancer	0.000257	0.002	CcSEcCtD
Trabectedin—Diarrhoea—Capecitabine—esophageal cancer	0.000253	0.00197	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000251	0.00195	CcSEcCtD
Trabectedin—Insomnia—Methotrexate—esophageal cancer	0.000249	0.00194	CcSEcCtD
Trabectedin—Paraesthesia—Methotrexate—esophageal cancer	0.000247	0.00192	CcSEcCtD
Trabectedin—Dyspnoea—Methotrexate—esophageal cancer	0.000245	0.00191	CcSEcCtD
Trabectedin—Dizziness—Capecitabine—esophageal cancer	0.000245	0.0019	CcSEcCtD
Trabectedin—Dyspepsia—Methotrexate—esophageal cancer	0.000242	0.00189	CcSEcCtD
Trabectedin—Decreased appetite—Methotrexate—esophageal cancer	0.000239	0.00186	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000238	0.00185	CcSEcCtD
Trabectedin—Fatigue—Methotrexate—esophageal cancer	0.000237	0.00185	CcSEcCtD
Trabectedin—Vomiting—Capecitabine—esophageal cancer	0.000235	0.00183	CcSEcCtD
Trabectedin—Rash—Capecitabine—esophageal cancer	0.000233	0.00181	CcSEcCtD
Trabectedin—Dermatitis—Capecitabine—esophageal cancer	0.000233	0.00181	CcSEcCtD
Trabectedin—Headache—Capecitabine—esophageal cancer	0.000232	0.0018	CcSEcCtD
Trabectedin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000225	0.00175	CcSEcCtD
Trabectedin—Nausea—Capecitabine—esophageal cancer	0.00022	0.00171	CcSEcCtD
Trabectedin—Body temperature increased—Methotrexate—esophageal cancer	0.000218	0.00169	CcSEcCtD
Trabectedin—Abdominal pain—Methotrexate—esophageal cancer	0.000218	0.00169	CcSEcCtD
Trabectedin—Hypersensitivity—Methotrexate—esophageal cancer	0.000203	0.00158	CcSEcCtD
Trabectedin—Asthenia—Methotrexate—esophageal cancer	0.000198	0.00154	CcSEcCtD
Trabectedin—Diarrhoea—Methotrexate—esophageal cancer	0.000188	0.00147	CcSEcCtD
Trabectedin—Dizziness—Methotrexate—esophageal cancer	0.000182	0.00142	CcSEcCtD
Trabectedin—Vomiting—Methotrexate—esophageal cancer	0.000175	0.00136	CcSEcCtD
Trabectedin—Rash—Methotrexate—esophageal cancer	0.000174	0.00135	CcSEcCtD
Trabectedin—Dermatitis—Methotrexate—esophageal cancer	0.000173	0.00135	CcSEcCtD
Trabectedin—Headache—Methotrexate—esophageal cancer	0.000172	0.00134	CcSEcCtD
Trabectedin—Nausea—Methotrexate—esophageal cancer	0.000164	0.00127	CcSEcCtD
Trabectedin—CYP2E1—Metabolism—ALOX15—esophageal cancer	3.48e-05	0.000188	CbGpPWpGaD
Trabectedin—SRC—Immune System—HMGB1—esophageal cancer	3.47e-05	0.000187	CbGpPWpGaD
Trabectedin—SRC—Disease—CALR—esophageal cancer	3.47e-05	0.000187	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	3.46e-05	0.000187	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GSTT1—esophageal cancer	3.44e-05	0.000186	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CYP2A6—esophageal cancer	3.4e-05	0.000184	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.39e-05	0.000183	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PLCE1—esophageal cancer	3.38e-05	0.000183	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ADH7—esophageal cancer	3.38e-05	0.000183	CbGpPWpGaD
Trabectedin—SRC—Disease—FBXW7—esophageal cancer	3.35e-05	0.000181	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CA2—esophageal cancer	3.34e-05	0.000181	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.34e-05	0.00018	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GSTO1—esophageal cancer	3.32e-05	0.000179	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—TPI1—esophageal cancer	3.32e-05	0.000179	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CA2—esophageal cancer	3.31e-05	0.000179	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HIST1H2BM—esophageal cancer	3.26e-05	0.000176	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—EGFR—esophageal cancer	3.25e-05	0.000175	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.24e-05	0.000175	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PDE4D—esophageal cancer	3.23e-05	0.000175	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ENO1—esophageal cancer	3.23e-05	0.000174	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CASP8—esophageal cancer	3.2e-05	0.000173	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CREBBP—esophageal cancer	3.19e-05	0.000172	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ALDOB—esophageal cancer	3.18e-05	0.000172	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PSME1—esophageal cancer	3.18e-05	0.000172	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PSME2—esophageal cancer	3.18e-05	0.000172	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NOS3—esophageal cancer	3.17e-05	0.000171	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PLCE1—esophageal cancer	3.11e-05	0.000168	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ADH7—esophageal cancer	3.11e-05	0.000168	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PLCE1—esophageal cancer	3.08e-05	0.000166	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ADH7—esophageal cancer	3.08e-05	0.000166	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GNG7—esophageal cancer	3.07e-05	0.000166	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GAPDH—esophageal cancer	3.06e-05	0.000165	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.05e-05	0.000165	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CRABP1—esophageal cancer	3.04e-05	0.000164	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—ERBB2—esophageal cancer	3.02e-05	0.000163	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.96e-05	0.00016	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—EGFR—esophageal cancer	2.94e-05	0.000159	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GNG7—esophageal cancer	2.89e-05	0.000156	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—XIAP—esophageal cancer	2.88e-05	0.000156	CbGpPWpGaD
Trabectedin—SRC—Immune System—ABL1—esophageal cancer	2.87e-05	0.000155	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TYMP—esophageal cancer	2.83e-05	0.000153	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PIK3CA—esophageal cancer	2.82e-05	0.000152	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.81e-05	0.000152	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.81e-05	0.000152	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.78e-05	0.00015	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.75e-05	0.000149	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—BCL2—esophageal cancer	2.75e-05	0.000149	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CYP1B1—esophageal cancer	2.74e-05	0.000148	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.73e-05	0.000147	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CTNNA1—esophageal cancer	2.72e-05	0.000147	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFBR2—esophageal cancer	2.71e-05	0.000146	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL2—esophageal cancer	2.71e-05	0.000146	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ALDH2—esophageal cancer	2.71e-05	0.000146	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.7e-05	0.000146	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.68e-05	0.000145	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—ERBB2—esophageal cancer	2.67e-05	0.000144	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TYMP—esophageal cancer	2.6e-05	0.000141	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TYMP—esophageal cancer	2.58e-05	0.000139	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CYP19A1—esophageal cancer	2.58e-05	0.000139	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GSTT1—esophageal cancer	2.57e-05	0.000139	CbGpPWpGaD
Trabectedin—SRC—Disease—SMAD4—esophageal cancer	2.57e-05	0.000139	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ERBB2—esophageal cancer	2.57e-05	0.000139	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTO1—esophageal cancer	2.56e-05	0.000138	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TPI1—esophageal cancer	2.56e-05	0.000138	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP2A6—esophageal cancer	2.54e-05	0.000137	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP26A1—esophageal cancer	2.53e-05	0.000137	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PSME2—esophageal cancer	2.53e-05	0.000137	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PSME1—esophageal cancer	2.53e-05	0.000137	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ANXA1—esophageal cancer	2.52e-05	0.000136	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.51e-05	0.000136	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ALOX15—esophageal cancer	2.47e-05	0.000133	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EP300—esophageal cancer	2.46e-05	0.000133	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ALDOB—esophageal cancer	2.46e-05	0.000133	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SST—esophageal cancer	2.45e-05	0.000132	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.45e-05	0.000132	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—EP300—esophageal cancer	2.41e-05	0.00013	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS1—esophageal cancer	2.41e-05	0.00013	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ENO1—esophageal cancer	2.41e-05	0.00013	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.39e-05	0.000129	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CA1—esophageal cancer	2.39e-05	0.000129	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH3—esophageal cancer	2.39e-05	0.000129	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GHRL—esophageal cancer	2.39e-05	0.000129	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PSME1—esophageal cancer	2.38e-05	0.000128	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PSME2—esophageal cancer	2.38e-05	0.000128	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GAPDH—esophageal cancer	2.36e-05	0.000128	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTO1—esophageal cancer	2.36e-05	0.000127	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TPI1—esophageal cancer	2.36e-05	0.000127	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—HMOX1—esophageal cancer	2.35e-05	0.000127	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FBXW7—esophageal cancer	2.35e-05	0.000127	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CRABP1—esophageal cancer	2.34e-05	0.000127	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.34e-05	0.000126	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TPI1—esophageal cancer	2.34e-05	0.000126	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.31e-05	0.000125	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CDKN1A—esophageal cancer	2.28e-05	0.000123	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ABCB1—esophageal cancer	2.26e-05	0.000122	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.26e-05	0.000122	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.24e-05	0.000121	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GNG7—esophageal cancer	2.23e-05	0.00012	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDKN1A—esophageal cancer	2.19e-05	0.000118	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CA2—esophageal cancer	2.19e-05	0.000118	CbGpPWpGaD
Trabectedin—SRC—Immune System—TLR4—esophageal cancer	2.18e-05	0.000117	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GAPDH—esophageal cancer	2.17e-05	0.000117	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EP300—esophageal cancer	2.17e-05	0.000117	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.16e-05	0.000116	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CRABP1—esophageal cancer	2.15e-05	0.000116	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH2—esophageal cancer	2.14e-05	0.000116	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.14e-05	0.000115	CbGpPWpGaD
Trabectedin—SRC—Disease—HIF1A—esophageal cancer	2.1e-05	0.000113	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—esophageal cancer	2.1e-05	0.000113	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ALDH2—esophageal cancer	2.09e-05	0.000113	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP1B1—esophageal cancer	2.05e-05	0.000111	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GNG7—esophageal cancer	2.05e-05	0.000111	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ADH7—esophageal cancer	2.03e-05	0.00011	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.03e-05	0.00011	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GNG7—esophageal cancer	2.03e-05	0.00011	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.99e-05	0.000107	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.96e-05	0.000106	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.96e-05	0.000106	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.93e-05	0.000104	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.92e-05	0.000104	CbGpPWpGaD
Trabectedin—SRC—Disease—NOS2—esophageal cancer	1.91e-05	0.000103	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.9e-05	0.000103	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFBR2—esophageal cancer	1.9e-05	0.000103	CbGpPWpGaD
Trabectedin—SRC—Disease—NOTCH1—esophageal cancer	1.89e-05	0.000102	CbGpPWpGaD
Trabectedin—SRC—Immune System—CASP8—esophageal cancer	1.87e-05	0.000101	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ENO1—esophageal cancer	1.86e-05	0.000101	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.86e-05	0.000101	CbGpPWpGaD
Trabectedin—SRC—Immune System—CREBBP—esophageal cancer	1.86e-05	0.0001	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—esophageal cancer	1.85e-05	0.0001	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PSME1—esophageal cancer	1.83e-05	9.9e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PSME2—esophageal cancer	1.83e-05	9.9e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.83e-05	9.87e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.81e-05	9.78e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.81e-05	9.75e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SMAD4—esophageal cancer	1.8e-05	9.71e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.79e-05	9.67e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PIK3CA—esophageal cancer	1.79e-05	9.64e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.78e-05	9.63e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.78e-05	9.62e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—esophageal cancer	1.78e-05	9.6e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.76e-05	9.5e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—esophageal cancer	1.73e-05	9.33e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CREBBP—esophageal cancer	1.72e-05	9.27e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.71e-05	9.24e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ENO1—esophageal cancer	1.71e-05	9.24e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.71e-05	9.23e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TYMP—esophageal cancer	1.7e-05	9.2e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ENO1—esophageal cancer	1.7e-05	9.16e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.7e-05	9.16e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ABCB1—esophageal cancer	1.69e-05	9.12e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PSME2—esophageal cancer	1.69e-05	9.11e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PSME1—esophageal cancer	1.69e-05	9.11e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PSME1—esophageal cancer	1.67e-05	9.03e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PSME2—esophageal cancer	1.67e-05	9.03e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.66e-05	8.95e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.61e-05	8.72e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PIK3CA—esophageal cancer	1.61e-05	8.68e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—BCL2—esophageal cancer	1.6e-05	8.65e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.6e-05	8.65e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.58e-05	8.55e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—ERBB2—esophageal cancer	1.56e-05	8.4e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CA—esophageal cancer	1.54e-05	8.34e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TPI1—esophageal cancer	1.54e-05	8.32e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.54e-05	8.32e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—NOS3—esophageal cancer	1.54e-05	8.3e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CREBBP—esophageal cancer	1.51e-05	8.16e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.49e-05	8.03e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.48e-05	7.97e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HIF1A—esophageal cancer	1.47e-05	7.94e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.46e-05	7.89e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.46e-05	7.86e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.44e-05	7.79e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—ERBB2—esophageal cancer	1.44e-05	7.76e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.42e-05	7.68e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.41e-05	7.61e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KDR—esophageal cancer	1.41e-05	7.6e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—esophageal cancer	1.4e-05	7.59e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.37e-05	7.39e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.36e-05	7.33e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.36e-05	7.33e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—NOS3—esophageal cancer	1.35e-05	7.3e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GNG7—esophageal cancer	1.34e-05	7.24e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.33e-05	7.19e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1A—esophageal cancer	1.33e-05	7.18e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH1—esophageal cancer	1.32e-05	7.16e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.3e-05	7.04e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—EP300—esophageal cancer	1.27e-05	6.83e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.26e-05	6.78e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.25e-05	6.74e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.24e-05	6.69e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—esophageal cancer	1.24e-05	6.68e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1A—esophageal cancer	1.23e-05	6.63e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.21e-05	6.56e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CREBBP—esophageal cancer	1.2e-05	6.49e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.2e-05	6.47e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.19e-05	6.45e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.19e-05	6.42e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.18e-05	6.38e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EP300—esophageal cancer	1.17e-05	6.31e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CREBBP—esophageal cancer	1.13e-05	6.1e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.12e-05	6.04e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ENO1—esophageal cancer	1.12e-05	6.04e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PSME2—esophageal cancer	1.1e-05	5.96e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PSME1—esophageal cancer	1.1e-05	5.96e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—esophageal cancer	1.08e-05	5.83e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOS3—esophageal cancer	1.08e-05	5.81e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—EP300—esophageal cancer	1.03e-05	5.56e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—esophageal cancer	1.02e-05	5.5e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NOS3—esophageal cancer	1.01e-05	5.46e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ERBB2—esophageal cancer	1.01e-05	5.43e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—esophageal cancer	9.96e-06	5.38e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.85e-06	5.32e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.51e-06	5.14e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CA—esophageal cancer	9.36e-06	5.06e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—esophageal cancer	9.24e-06	4.99e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.98e-06	4.85e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.95e-06	4.83e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—esophageal cancer	8.89e-06	4.8e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CREBBP—esophageal cancer	8.71e-06	4.7e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CA—esophageal cancer	8.64e-06	4.67e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1A—esophageal cancer	8.6e-06	4.64e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EP300—esophageal cancer	8.18e-06	4.42e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.16e-06	4.41e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CREBBP—esophageal cancer	8.01e-06	4.33e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CREBBP—esophageal cancer	7.94e-06	4.29e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.84e-06	4.23e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NOS3—esophageal cancer	7.8e-06	4.21e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—EP300—esophageal cancer	7.69e-06	4.15e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CA—esophageal cancer	7.61e-06	4.11e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NOS3—esophageal cancer	7.17e-06	3.87e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—esophageal cancer	7.13e-06	3.85e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—esophageal cancer	7.13e-06	3.85e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NOS3—esophageal cancer	7.11e-06	3.84e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—esophageal cancer	6.97e-06	3.77e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—esophageal cancer	6.56e-06	3.54e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—esophageal cancer	6.5e-06	3.51e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CA—esophageal cancer	6.05e-06	3.27e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—EP300—esophageal cancer	5.93e-06	3.2e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—esophageal cancer	5.85e-06	3.16e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CA—esophageal cancer	5.69e-06	3.07e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—EP300—esophageal cancer	5.45e-06	2.95e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—EP300—esophageal cancer	5.41e-06	2.92e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.24e-06	2.83e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NOS3—esophageal cancer	4.69e-06	2.53e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CA—esophageal cancer	4.39e-06	2.37e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.29e-06	2.32e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CA—esophageal cancer	4.04e-06	2.18e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CA—esophageal cancer	4e-06	2.16e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—EP300—esophageal cancer	3.57e-06	1.93e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.64e-06	1.42e-05	CbGpPWpGaD
